Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain
about
Quantitative distribution and colocalization of non-muscle myosin light chain kinase isoforms and cortactin in human lung endotheliumTreatment of Cancer Pain by Targeting CytokinesEmerging Relationships between Exercise, Sensory Nerves, and Neuropathic PainEndocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain.Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedsideKey role for spinal dorsal horn microglial kinin B1 receptor in early diabetic pain neuropathy.Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptorsHIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities.Viral Infection of the Central Nervous System and Neuroinflammation Precede Blood-Brain Barrier Disruption during Japanese Encephalitis Virus Infection.Short small-interfering RNAs produce interferon-α-mediated analgesiaEffects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cellsCrosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?Deciphering the modulation of gene expression by type I and II interferons combining 4sU-tagging, translational arrest and in silico promoter analysis.Interferon alpha inhibits spinal cord synaptic and nociceptive transmission via neuronal-glial interactions.Glia and pain: is chronic pain a gliopathy?Current evidence for a modulation of low back pain by human genetic variants.Activation of Both CB1 and CB2 Endocannabinoid Receptors Is Critical for Masculinization of the Developing Medial Amygdala and Juvenile Social Play Behavior.Dynamic regulation of the endocannabinoid system: implications for analgesia.The endocannabinoid system: a revolving plate in neuro-immune interaction in health and disease.Microglia and intractable chronic pain.Dynamic changes to the endocannabinoid system in models of chronic pain.Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.No more pain upon Gq-protein-coupled receptor activation: role of endocannabinoids.Modulating the delicate glial-neuronal interactions in neuropathic pain: promises and potential caveats.Neuropathic pain: role of inflammation, immune response, and ion channel activity in central injury mechanisms.Spinal cord injury induced neuropathic pain: Molecular targets and therapeutic approaches.Vitamin B12-responsive neuropathies: A case series.Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?P2 receptors, microglial cytokines and chemokines, and neuropathic pain.Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium.Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.Differential changes in GPR55 during microglial cell activation.Cannabinoid Receptor 2 Modulates Susceptibility to Experimental Cerebral Malaria through a CCL17-dependent Mechanism.Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels.Cytokine expression in the epidural space: a model of noncompressive disc herniation-induced inflammationInterferon-gamma potentiates NMDA receptor signaling in spinal dorsal horn neurons via microglia-neuron interaction.Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes.Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice.
P2860
Q24294241-BCF41385-9E49-409A-8D70-7A0C8B0885DCQ26779917-82EA646A-0D41-412F-A53B-E7241F39C77DQ28066195-F02E9D37-B66D-4E15-BA81-80FEB6947BFAQ30473707-BABF01F2-08D6-49B6-856D-3C05741DA299Q33713080-E7F3786E-4667-4B81-9724-5167E43D5C39Q34019573-E133A9A2-3AEE-40B9-8495-F41AFC38E9D6Q34036011-D81181A6-6569-4B58-9A66-5944188D3BC7Q34116825-2AFC0E14-B359-47CA-BA27-5D3252B813FFQ34993393-63318A01-4ACC-4167-97F1-884D8B170A54Q35103574-376C46EF-EE3B-4AE0-9C1B-20375F130617Q35641478-E08E5563-25B6-490A-B27F-9E8739A9E933Q35829482-449BE6CF-87D8-4EE8-9A95-79D25EDD29B9Q36347677-98CE6D71-E2E0-4EFB-A194-CA1E67217ACEQ36789308-423069A8-994E-4101-B5FC-E3A7BD580A96Q37197803-8C865742-C4A3-49F6-9539-1EB09F413D53Q37285609-E925288C-0A89-44F5-8F26-0B9CE0C02E2FQ37381399-ED795B9E-C717-41AB-9FE9-86B69204F74DQ37396519-EAF7CB16-0FC0-4823-814A-3F0906B08499Q37610851-536F846C-A876-4921-855B-8CCFF532EBF0Q37611106-13E2DDCA-9B75-4DDB-A293-72252F4F2C01Q37988405-0C7C9AC5-09E0-4963-B9EE-8516FE322C13Q38022210-CF8C093E-9DCC-4B2E-8154-65140F9A3028Q38056398-11A07DC5-3937-4390-93CA-C5F1F244C88EQ38087533-8192BC3E-649D-4CB1-85DA-106ACCC80C45Q38185075-06871CB8-13B1-480B-B1A3-ADA39DA225FEQ38211273-ED148449-02C9-4E88-9799-D52B3EBB8468Q38247950-D39289B2-A868-4153-A923-27FD85FC60E1Q38318458-1099C848-6895-4672-960C-F3EDD4BBFD12Q38364736-439BDD56-54CA-4C4A-9301-9B9650F804AAQ38748394-5043F034-5F5C-40BF-A27A-ECF89D7EF51EQ38885571-64B58566-E504-4CDE-9E09-00A0A0529934Q39077826-CC444D5E-8321-4053-9913-F3B8FE693185Q39248070-D1843DDC-6899-4CC2-BE0F-095DA33B318FQ39847881-AA7F3FA2-0D0D-44D3-A2BD-E8A8D058D9DCQ40594444-430792CE-046F-4FF8-9BE7-A11517BBCBE5Q41785702-92B8FC3E-A9F8-4D08-955A-794269AB34E3Q41930415-C017FAC4-915B-4078-A48A-D1622E94CEB4Q42155319-BD83D9CA-5956-4B06-899D-EF0D7373F28FQ48639392-6239E45A-1079-4DCB-8465-492527760F5EQ50668498-41AE49F5-34B0-4C37-9BC7-F95119546BF8
P2860
Interferon-gamma is a critical modulator of CB(2) cannabinoid receptor signaling during neuropathic pain
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Interferon-gamma is a critical ...... naling during neuropathic pain
@ast
Interferon-gamma is a critical ...... naling during neuropathic pain
@en
Interferon-gamma is a critical ...... naling during neuropathic pain
@nl
type
label
Interferon-gamma is a critical ...... naling during neuropathic pain
@ast
Interferon-gamma is a critical ...... naling during neuropathic pain
@en
Interferon-gamma is a critical ...... naling during neuropathic pain
@nl
prefLabel
Interferon-gamma is a critical ...... naling during neuropathic pain
@ast
Interferon-gamma is a critical ...... naling during neuropathic pain
@en
Interferon-gamma is a critical ...... naling during neuropathic pain
@nl
P2093
P2860
P921
P3181
P1476
Interferon-gamma is a critical ...... naling during neuropathic pain
@en
P2093
Alfonso Gutierrez-Adan
Andreas Zimmer
Belén Pintado
Elena Sanguino
Ildiko Racz
Jennifer Rehnelt
Jorge Manzanares
Josep E Baños
Judith Alferink
Miquel Martín
P2860
P304
P3181
P356
10.1523/JNEUROSCI.3402-08.2008
P407
P577
2008-11-12T00:00:00Z